We’re changing the game for #ColorectalCancer screening w/ the FDA approval of Shield, our blood test for people age 45+ at average risk. With Shield, we aim to get more people tested & catch more cancers early, when they’re most treatable.
Read more: https://t.co/oQj60CjBfs
Digital content management platform Greenfly has raised $14 million in new venture capital funding led by ADvantage, the sports tech investing fund of the Dassler family of Adidas fame. https://t.co/M2wFm3wnHp
Register now: Llama Lounge Nov 2, Palo Alto at the iconic @hanahaus. Ten startups on the demo floor, keynote by @chrisyeh#llamalounge
https://t.co/Y1sbZtOms2
@Exon20Group Based on this data (which echoes much of the Chinese data already known), would it be fair to say Furmonertinib has potential to be exon20ins community's answer to Osimertinib for more common EGFR mutations? That is, a first line oral standard with relatively high PFS?
@SD_Toki Lily is a fantastic woman & lucky to have you, @SD_Toki . Fellow exon20ins caregiver here. Let me know if you want to talk. Just follow back & dm. ♥️
Greenfly is excited to announce our acquisition of @usemiro, the sports industry’s most advanced AI tech for real-time contextual analysis of sports contentGreenfly is excited to announce our acquisition of @usemiro, the sports industry’s most advanced AI tech for real-time contextual analysis of sports content!
@mrossana We used to go down south there. Hair slicked back, white bathing suits, you know the drill...
People can change, Matt.
https://t.co/x8TESdOcRZ
It’s week 2, day 1 of our Cohort Spotlights, and we’re so excited to introduce you all to @useMiro! Using computer vision and AI, @useMiro empowers events, brands, and athletes. Swipe to learn more about them!
#pokatok#sportstech#sports#ai#computervision#nfl#nba#nhl#mlb